Health Professionals

Dr Petrella on Selecting Frontline Therapy in Metastatic Melanoma

Teresa Petrella, MD, MHSc, FRCPC, medical oncologist, affiliate scientist, Evaluative Clinical Sciences, Odette Cancer Research Program, Sunnybrook Research Institute; and associate professor, Department of Medicine, University of Toronto, discusses key considerations in selecting frontline therapy for patients with metastatic melanoma based on long-term survival data and therapeutic sequencing findings.

Read More
MRV News
Melanoma News
Archive
Menu